Robison, N., Pauly, J., Malvar, J., Gardner, S., Allen, J., Margol, A., MacDonald, T., Bendel, A., Kilburn, L., Cluster, A., Bowers, D., Dorris, K., Ullrich, N., De Mola, R. L., Alva, E., Leary, S., Baxter, P., Khatib, Z., Cohen, K., Davidson, T. B., Plant, A., Bandopadhayay, P., Stopka, S., Agar, N., Wright, K., Nelson, M., Chi, Y., & Kieran, M. (n.d.). lTBK-04. LATE BREAKING ABSTRACT: MEK162 (binimetinib) in children with progressive or recurrent low-grade glioma: a multi-institutional phase II and target validation study. Neuro-oncology, 24, i191–i192. http://access.bl.uk/ark:/81055/vdc_100156699795.0x00001d